Status:
UNKNOWN
Fractional Laser Versus Radiofrequency in Androgenetic Alopecia
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Androgenic Alopecia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Patients with Androgenetic alopecia will be randomized into 2 groups; Group FCO2 receiving Fractional CO2 or Group FRF receiving Fractional Microneedling Radiofrequency.
Detailed Description
Group FCO2 will be to receiving fractional CO2 to one randomized side of the scalp, and Group FRF will be receiving Fractional Microneedling radiofrequency to one randomized side of the scalp. All pa...
Eligibility Criteria
Inclusion
- • both genders are included.
- Patients above 18 years old.
Exclusion
- • Patients with patchy hair loss.
- Patients with Telogen Effluvium or diffuse alopecia areata.
- Patients with cicatricial alopecias.
- Patients with associated inflammatory scalp disorders such as psoriasis or seborrheic dermatitis.
- Patients with collagen vascular disorders.
- Prior use of topical steroids on scalp in the previous 2 weeks.
- Prior use of systemic steroids in the previous 1 month.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05435625
Start Date
January 1 2022
End Date
December 1 2022
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Al Ainy Hospital
Cairo, El Manial, Egypt, 11956